Cbl-b-IN-29, CAS [[3070411-10-5]] Preis auf Anfrage

Produktübersicht

• Artikelname: Cbl-b-IN-29, CAS [[3070411-10-5]] Preis auf Anfrage
• Artikelnummer: MCE-HY-179575
• Hersteller Artikelnummer: HY-179575
• Alternativnummer: MCE-HY-179575-1UNIT
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

Cbl-b-IN-29 is an orally active CBL-B inhibitor. Cbl-b-IN-29 binds to the CBL-B active pocket. Cbl-b-IN-29 induces Jurkat cell release IL-2 with an EC50 of 159 nM, effectively inhibiting the function of immune E3 ubiquitin ligase. Cbl-b-IN-29 demonstrates robust anti-tumor efficacy in vivo with good tolerability and no observed adverse reactions. Cbl-b-IN-29 can be used for cancer immunotherapy, colorectal cancer and immune-oncology combination research[1].

Produkteigenschaften

• Molekulargewicht: 499.62
• CAS Nummer: [3070411-10-5]
• Formel: C30H34FN5O
• Target-Kategorie: E1/E2/E3 Enzyme,Interleukin Related

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound